UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

Gut, 2020-07, Vol.69 (7), p.1206-1212

2020

Volltextzugriff (PDF)

Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis

The lancet. Gastroenterology & hepatology, 2021-12, Vol.6 (12), p.1002-1014

2021

Volltextzugriff (PDF)

Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study

Arthritis & rheumatology (Hoboken, N.J.), 2013-09, Vol.65 (9), p.2368-2379

2013

Volltextzugriff (PDF)

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1259-1266

2016

Volltextzugriff (PDF)

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysis

Alimentary pharmacology & therapeutics, 2015-04, Vol.41 (8), p.734-746

2015

Volltextzugriff (PDF)

Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica

Neurology, 2011-08, Vol.77 (7), p.659-666

2011

Volltextzugriff (PDF)

A randomized trial of methotrexate versus azathioprine for severe atopic eczema

Journal of allergy and clinical immunology, 2011-08, Vol.128 (2), p.353-359

2011

Volltextzugriff (PDF)

Optimizing thiopurine therapy in autoimmune hepatitis: A multicenter study on monitoring metabolite profiles and co-therapy with allopurinol

Hepatology (Baltimore, Md.), 2024-11, Vol.80 (5), p.1026-1040

2024

Volltextzugriff (PDF)

Reply to: Comments on “An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis”

Journal of hepatology, 2024-07, Vol.81 (1), p.e43-e44

2024

Volltextzugriff (PDF)

Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy

Journal of hepatology, 2024-07, Vol.81 (1), p.e41-e42

2024

Volltextzugriff (PDF)

British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis

Gut, 2011-12, Vol.60 (12), p.1611-1629

2011

Volltextzugriff (PDF)

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Arthritis & rheumatology (Hoboken, N.J.), 2013-09, Vol.65 (9), p.2441-2449

2013

Volltextzugriff (PDF)

Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials

Scandinavian journal of gastroenterology, 2024-06, Vol.59 (6), p.669-673

2024

Volltextzugriff (PDF)

Pulse azathioprine and low-dose methotrexate vs. standard-dose methotrexate in treatment of patients with moderate-to-severe psoriasis: a randomized controlled trial

Clinical and experimental dermatology, 2024-08, Vol.49 (9), p.1029-1035

2024

Volltextzugriff (PDF)

The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis

Scientific reports, 2020-04, Vol.10 (1), p.6062, Article 6062

2020

Volltextzugriff (PDF)

Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents

The Journal of pediatrics, 2013-11, Vol.163 (5), p.1347-1353.e1

2013

Volltextzugriff (PDF)

A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis

Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (10), p.1035-1047

2016

Volltextzugriff (PDF)

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

Gut, 2011-07, Vol.60 (7), p.930-936

2011

Volltextzugriff (PDF)

Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab

Digestive and liver disease, 2024-05, Vol.56 (5), p.737-743

2024

Volltextzugriff (PDF)

Development and in vivo evaluation of chitosan beads for the colonic delivery of azathioprine for treatment of inflammatory bowel disease

European journal of pharmaceutical sciences, 2017-11, Vol.109, p.269-279

2017

Volltextzugriff (PDF)

Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1279-1286

2016

Volltextzugriff (PDF)

Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)

Journal of gastroenterology, 2019-10, Vol.54 (10), p.860-870

2019

Volltextzugriff (PDF)

Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study

Journal of the American Academy of Dermatology, 2016-07, Vol.75 (1), p.49-58

2016

Volltextzugriff (PDF)

Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease

Alimentary pharmacology & therapeutics, 2014-01, Vol.39 (2), p.163-175

2014

Volltextzugriff (PDF)

Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials

Journal of hepatology, 2010-07, Vol.53 (1), p.191-198

2010

Volltextzugriff (PDF)

1 – 25 von 859

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Transplantation

SprachePortugiesisch

ThemaImmunosuppressive Agents - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(738)
Mit Volltextzugriff
(543)

Publikationsform

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(825)
Azathioprine - Therapeutic Use
(716)
Science & Technology
(602)
Life Sciences & Biomedicine
(593)
Female
(491)
Immunosuppressive Agents - Administration & Dosage
(478)
Male
(468)
Azathioprine - Administration & Dosage
(457)
Adult
(407)
Drug Therapy, Combination
(342)
Middle Aged
(322)
Biological And Medical Sciences
(237)
Medical Sciences
(237)
Immunosuppressive Agents - Adverse Effects
(192)
Treatment Outcome
(184)
Cyclosporine - Therapeutic Use
(183)
Time Factors
(181)
Adolescent
(161)
Azathioprine
(161)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis

Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysis

Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica

A randomized trial of methotrexate versus azathioprine for severe atopic eczema

Optimizing thiopurine therapy in autoimmune hepatitis: A multicenter study on monitoring metabolite profiles and co-therapy with allopurinol

Reply to: Comments on “An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis”

Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy

British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials

Pulse azathioprine and low-dose methotrexate vs. standard-dose methotrexate in treatment of patients with moderate-to-severe psoriasis: a randomized controlled trial

The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis

Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents

A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab

Development and in vivo evaluation of chitosan beads for the colonic delivery of azathioprine for treatment of inflammatory bowel disease

Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment

Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)

Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study

Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease

Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials

Aktive Filter

Suchergebnisse filtern